Hyderabad’s UR Advanced Therapeutics Launches ‘Bio Varam’ Brand
The company will roll out research-use kits across India within five working days to help innovators from academia to industry
Hyderabad: UR Advanced Therapeutics, a Hyderabad-based biotech company incubated at the University of Hyderabad’s ASPIRE, has launched its new brand, ‘Bio Varam’, to make advanced regenerative medicine and diagnostic solutions accessible to everyone.
The launch event was held at the School of Life Sciences, University of Hyderabad, with Dr K.I. Varaprasad Reddy, founder of Shantha Biotech, as chief guest. He asked the team to ensure that regenerative therapies become a right for all, just as Shanvac made life-saving vaccines affordable.
Bio Varam’s founder, Dr Jaganmohan Reddy, said their aim was to create a sustainable, AI-driven innovation hub, delivering world-class technologies in regenerative medicine and diagnostics. The company will roll out research-use kits across India within five working days to help innovators from academia to industry.
The company plans to develop diagnostic and therapeutic products in tissue engineering, oncology, ophthalmology, and immune modulation. It is also starting a ‘Founders-in-Residence’ programme to support promising biotech entrepreneurs. Chief operating officer Dr Aparna Rachamallu said their priority is to give researchers quick access to peptide tools and diagnostics without compromising on quality or affordability.
Bio Varam specialises in AI-designed peptides, exosome-based diagnostics, and biomaterials like atelocollagen and peptide scaffolds for tissue-specific regeneration. Its facilities include molecular biology labs, peptide synthesis platforms, and advanced analytical suites.
The company has won several awards, including the Start-up Maharathi Challenge 2025 and the IKP Rise Award 2025. Initial support came from Bhavya Constructions, ASPIRE, BioCyTiHFoundation, and the Biotechnology Ignition Grant.